Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Gamma-secretase

Gamma secretase is a multi-subunit protease complex, itself an integral membrane protein, that cleaves single-pass transmembrane proteins at residues within the transmembrane domain. Proteases of this type are known as intramembrane proteases. The most well-known substrate of gamma secretase is amyloid precursor protein, a large integral membrane protein that, when cleaved by both gamma and beta secretase, produces a short 37-43[verification needed] amino acid peptide called amyloid beta whose abnormally folded fibrillar form is the primary component of amyloid plaques found in the brains of Alzheimer's disease patients. Gamma secretase is also critical in the related processing of several other type I integral membrane proteins, such as Notch, ErbB4, E-cadherin, N-cadherin, ephrin-B2, or CD44.

DAPT
T6202208255-80-5
DAPT (LY-374973) is a γ-secretase inhibitor that inhibits total Aβ and Aβ42 (IC50=115/200 nM) and is orally active. DAPT is also a Notch inhibitor. DAPT induces cell differentiation, autophagy and apoptosis.
  • $53
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
γ-Secretase-IN-1
T3521209986-17-4
γ-Secretase-IN-1 is a potent γ-secretase inhibitor that displays partial antiproliferative activity on T-47D cells and inhibits β-amyloid(40), β-amyloid(42), and Notch γ-secretase cleavage.
  • $129
In Stock
Size
QTY
RO7185876
T397022226038-71-5In house
RO7185876 is a selective gamma secretase modulator, which can be used in the study of Alzheimer's disease.
  • $293 TargetMol
In Stock
Size
QTY
Crenigacestat
T36331421438-81-4
Crenigacestat (LY3039478) is an orally bioavailable Notch inhibitor with an IC50 of ~1 nM in most tumor cell lines tested. It effectively inhibits mutant Notch receptor activity and, in a xenograft tumor model, inhibits the expression of Notch-regulated genes and N1ICD cleavage in the tumor microenvironment.
  • $56
In Stock
Size
QTY
TargetMol | Citations Cited
γ-Secretase modulator 13
T622631353570-40-7In house
γ-Secretase modulator 13 is a γ-secretase modulator (GSMs) that inhibits the production of amyloid β-peptide Aβ42 and can be used to study Alzheimer's disease and tumors.
  • $293 TargetMol
In Stock
Size
QTY
BMS-906024
T146801401066-79-2In house
BMS-906024 (Osugacestat) is an orally available and selective inhibitor of γ-secretase, a small molecule Notch inhibitor.BMS-906024 has broad-spectrum antitumour activity against a variety of human cancer xenografts.BMS-906024 prevents the activation of all four Notch receptors, and is active against Notch1, -2, -3 and -4 receptors. BMS-906024 prevents the activation of all four Notch receptors, with IC50s of 1.6, 0.7, 3.4 and 2.9 nM for Notch1, -2, -3 and -4 receptors, respectively.
  • $565
In Stock
Size
QTY
RBPJ Inhibitor-1
T355662682114-39-0
RBPJ Inhibitor-1 (RIN1), a compound that impedes the functional interaction between RBPJ and SHARP, effectively inhibits NOTCH-dependent tumor cell proliferation[1].
  • $34
In Stock
Size
QTY
JI051
T117182234281-75-3
JI051 is an antitumor agent that interacts with the cancer-associated protein chaperone prohibitin 2 (PHB2) to induce cell cycle arrest by inhibiting the transcription of the Notch downstream effector gene, Hes1, and inhibits the proliferation of HEK293 cells and pancreatic cancer cells.
  • $58
In Stock
Size
QTY
YO-01027
T6135209984-56-5In house
YO-01027 (DBZ) is a potent γ-secretase inhibitor.
  • $44
In Stock
Size
QTY
TargetMol | Citations Cited
MDR-1339
TQ00261018946-38-7
MDR-1339 (DWK-1339) is an orally active, blood-brain-barrier-permeable inhibitor of amyloid-β (Aβ) aggregation.
  • $54
In Stock
Size
QTY
L-685458
T6870292632-98-5
L-685458 (L-685,458) is a specific and potent inhibitor of A beta PP gamma-secretase activity with Ki of 17 nM.
  • $122
In Stock
Size
QTY
TargetMol | Inhibitor Sale
RO4929097
T6274847925-91-1
RO4929097 (RG-4733), a γ secretase inhibitor (IC50: 4 nM), inhibits cellular processing of Aβ40 and Notch (EC50: 14/5 nM).
  • $40
In Stock
Size
QTY
TargetMol | Inhibitor HotTargetMol | Inhibitor Sale
LY-411575
T6063209984-57-6
LY-411575, a potent γ-secretase inhibitor, is with IC50 of 0.078 nM in the membrane and 0.082 nM in cell-based. It also suppresses Notch clevage with IC50 of 0.39 nM.
  • $38
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
MRK-560
T16133677772-84-8
MRK-560 is an effective and brain-penetrant inhibitor of γ-secretase.
  • $35
In Stock
Size
QTY
Bruceine D
TWS204521499-66-1
1. Bruceine D from Brucea javanica, may have the potential to be used as a natural viricide, or a lead compound for new viricides. 2. Bruceine D inhibits the growth of three pancreatic cancer cell lines, i.e., PANC-1, SW199 and CAPAN-1; induces cytotoxicity in Capan-2 cells via the induction of cellular apoptosis involving the mitochondrial pathway.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Jagged-1 (188-204) TFA(219127-21-6 free base)
TP1293
Jagged-1 (188-204) TFA(219127-21-6 free base) is a fragment of the JAG-1 protein. JAG-1 is Notch ligand, a peptide that is the most conspicuously expressed ligand in skin. JAG-1 induces epidermal maturation. Exposing submerged keratinocytes monolayers to JAG-1 with elevated calcium concentration produces stratification with loricrin expression and NF-alphaB activation.
  • $235
In Stock
Size
QTY
TargetMol | Inhibitor Hot
NGP555
T162941304630-27-0
NGP555 is a modulator of γ-secretase.
  • $71
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Gossypolone
T319874547-72-2In house
Gossypolone is is a proposed major metabolite of gossypol. Gossypolone reduces Notch Wnt signaling and induces apoptosis.
  • $195
In Stock
Size
QTY
Nirogacestat
T69351290543-63-3
Nirogacestat (PF 03084014) is a specific γ-secretase inhibitor (IC50: 6.2 nM, in a cell-free assay).
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Valproic acid sodium salt
T16021069-66-5
Valproic acid sodium salt (Sodium Valproate) is the sodium salt form of valproic acid with anti-epileptic activity. Valproic acid sodium salt is converted into its active form, valproate ion, in blood. Although the mechanism of action remains to be elucidated, Valproic acid sodium salt increases concentrations of gamma-aminobutyric acid (GABA) in the brain, probably due to inhibition of the enzymes responsible for the catabolism of GABA. This potentiates the synaptic actions of GABA. Valproic acid sodium salt may also affect potassium channels, thereby creating a direct membrane-stabilizing effect.
  • $42
In Stock
Size
QTY
TargetMol | Citations Cited
Tangeretin
T2842481-53-8
Tangeretin (NSC-618905), a flavonoid from citrus fruit peels, has been proven to play an important role in anti-inflammatory responses and neuroprotective effects in several disease models and was also selected as a Notch-1 inhibitor.
  • $47
In Stock
Size
QTY
ELN318463 racemate
T11178L851599-82-1In house
ELN318463 racemate (ELN 318463 racemate) is the racemate of ELN318463 which is an amyloid precursor protein (APP) selective γ-secretase inhibitor.
  • $165
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Psoralidin
T339918642-23-4
Psoralidin inhibits Akt phosphorylation and phosphatidylinositol 3-kinase activation and transcriptionally. Psoralidin possesses anticancer and chemopreventive properties.
  • $57
In Stock
Size
QTY
TargetMol | Inhibitor Sale
FLI-06
T3075313967-18-9
FLI-06 is a Notch signaling inhibitor (EC50: 2.3 μM).
  • $30
In Stock
Size
QTY
Itanapraced
T2262749269-83-8
Itanapraced (CHF5074), a γ-secretase modulator, reduces Aβ42/40 secretion (IC50: 3.6/18.4 μM).
  • $43
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Ro 90-7501
T16773293762-45-5In house
Ro 90-7501 is an amyloid β42 (Aβ42) protofibrillar and TPR-dependent PP5 inhibitor, a novel radiosensitizer for cervical cancer cells, which inhibits ATM phosphorylation, promotes apoptosis, and induces cell-cycle arrest. Ro 90-7501 also exhibits antiviral activity and potential anticancer activity by inhibiting ATM phosphorylation and DNA repair, and by inhibiting HCMV.
  • $30
In Stock
Size
QTY
gamma-secretase modulator 1
T113581172637-87-4In house
gamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
ZLDI-8
T13410667880-38-8
ZLDI-8 is an inhibitor of Notch activating/cleaving enzyme ADAM-17 and inhibits the cleavage of Notch protein.
  • $52
In Stock
Size
QTY
CIA-1 (Free base)
T71534L452087-38-6
CIA-1 (Free base) is a nuclear receptor COUP-TFII inhibitor with IC50 values ranging from 1.2 μM to 7.6 μM in prostate cancer cell lines. CIA-1 (Free base) inhibits tumor growth in a mouse model of prostate cancer xenografts.
  • $52
In Stock
Size
QTY
Semagacestat
T6125425386-60-3
Semagacestat (LY450139) (LY450139) is a γ-secretase blocker for Aβ42 Aβ40 Aβ38 (IC50: 10.9 12.1 12.0 nM) and also inhibits Notch signaling (IC50: 14.1 nM).
  • $34
In Stock
Size
QTY
DAPM
T86161208255-51-0
DAPM (gamma-Secretase Inhibitor XVI) is a Notch pathway inhibitor with anticancer activity and antiproliferative effects, inhibits cell proliferation and induces the expression of Krüppel-like Factor 4 (KLF4) and p21 in human colon cancer cells, inhibits Notch signaling, and can be used in the study of renal tubular adenomas.
  • $72
In Stock
Size
QTY
MK-0752
T2625471905-41-6
MK-0752, a γ-secretase inhibitor, reduces Aβ40 production(IC50=5 nM).
  • $52
In Stock
Size
QTY
PE859
T40771402727-29-0
PE859 is a potent inhibitor of the aggregation of both tau and Aβ.
  • $61
In Stock
Size
QTY
LY900009
T9015209984-68-9
LY900009 is a small molecule inhibitor of Notch signalling via selective inhibition of the γ-secretase protein.
  • $32
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Rovalpituzumab
T766981613313-01-1
Rovalpituzumab is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3) and is utilized to synthesize antibody-active molecule conjugates (ADCs). It exhibits anticancer activity and is used in the treatment of small cell lung cancer (SCLC).
  • $178
In Stock
Size
QTY
5β-Cholanic acid
T88859546-18-9
5β-Cholanic acid (5beta-Cholanic acid) is a potent γ-secretase modulator used in Alzheimer's disease research.
  • $37
In Stock
Size
QTY
IMR-1A
T3540331862-41-0
IMR-1A is the metabolite of IMR-1 which is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.
  • $68
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
CB-103
T12246218457-67-1
CB-103 is a orally active inhibitor of notch signaling pathway, with anti-tumor activity.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Sale
E 2012
T15184870843-42-8
E2012 is a γ-secretase modulator (GSM). E2012 inhibits 3β-hydroxysterol Δ24-reductase (DHCR24) at the final step in the cholesterol biosynthesis. E 2012 aims at Alzheimer's disease by reduction of amyloid β-42, and induces cataract following repeated doses in the rat.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
BMS 299897
T14673290315-45-6
BMS 299897 is a sulfonamide γ-secretase inhibitor with an IC50 of 7 nM for inhibiting Aβ production in HEK293 cells stably overexpressing amyloid precursor protein (APP).
  • $52
In Stock
Size
QTY
Cimigenoside
T6S167627994-11-2
Cimigenoside, a constituent of Asclepias, is a γ-secretase inhibitor that inhibits the proliferation or metastasis of human breast cancer cells via the γ-secretase Notch axis.
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Sale
IMR-1
T6861310456-65-6
IMR-1, a novel class of Notch inhibitors, targets transcriptional activation with an IC50 of 6 μMol L.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
JLK6
T2189062252-26-0
JLK6 was a gamma-secretase inhibitor that does not interfere with Notch signalling
  • $133
In Stock
Size
QTY
Fosciclopirox
T94221380539-06-9
Fosciclopirox (CPX-POM), the phosphoryloxymethyl ester of CPX (Ciclopirox Prodrug, CPX-POM), selectively delivers the active metabolite, CPX, to the entire urinary tract following parenteral administration.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Avagacestat
T62491146699-66-2
Avagacestat (BMS-708163) (BMS-708163) is a potent, selective, orally bioavailable γ-secretase inhibitor of Aβ40 and Aβ42 with IC50 of 0.3 nM and 0.27 nM, demonstrating a 193-fold selectivity against Notch. Phase 2.
  • $57
In Stock
Size
QTY
Aβ-IN-1
T632082766509-32-2In house
Aβ-IN-1 is a novel, potent and orally active γ-secretase modulator (GSM). Aβ-IN-1 potently reduced Aβ42 levels with an IC 50 value of 0.091 μM in cultured cells without inhibiting CYP3A4. Aβ-IN-1 shows a sustained pharmacokinetic profile.
  • $350
In Stock
Size
QTY
BI-1408
T105322231075-94-6In house
BI-1408 is a modulator potent of γ secretase (IC50: 0.04 μM for Aβ42).
  • $350
In Stock
Size
QTY
HDAC6-IN-9
T608562796282-58-9
HDAC6-IN-9 is an orally active and highly effective γ-secretase modulator that can significantly reduce the level of Aβ42 in mouse brain and can be used to study neurological diseases.
  • $293
In Stock
Size
QTY